Back
Corporate News
Fredun Pharmaceuticals to review quarterly results at board meeting on August 5, 2026
30-Jul-2026, 07:27
Fredun Pharmaceuticals Limited will hold a board meeting on Wednesday, August 5, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2026, according to a regulatory filing with the BSE Limited. The trading window for the company's securities will remain closed for 48 hours after the financial results are declared, as per Securities and Exchange Board of India regulations.
Fredun Pharmaceuticals Limited will hold a board meeting on Wednesday, August 5, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2026, according to a regulatory filing with the BSE Limited. The trading window for the company's securities will remain closed for 48 hours after the financial results are declared, as per Securities and Exchange Board of India regulations.